Mobile Digital Biomarkers for Identifying Progressing MS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for multiple sclerosis (MS) are not specific and require repetitive clinical and MRI investigations to confirm disease dissemination, lacking a reliable means for identifying progressing forms of MS.
Innovation Solution
A method using a mobile device to perform a Squeeze a Shape test, determining performance parameters such as the number of squeezed shapes and pinching precision, and comparing these to a reference to identify progressing MS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current diagnostic methods for multiple sclerosis are used, then diagnosis can be performed, but the methods are not specific and require repetitive clinical and MRI investigations to confirm disease dissemination
Solution Approach 1:
The patent replaces traditional mechanical/physical diagnostic methods (clinical examinations and MRI investigations) with a digital sensor-based system that uses a mobile device to capture performance parameters. This substitution eliminates the need for repetitive clinical and MRI investigations while maintaining diagnostic reliability through automated, consistent digital measurements of motor function, cognitive ability, and other physiological parameters.
Solution Approach 2:
The patent creates a digital copy of clinical assessment functionality within a mobile device. Instead of requiring physical presence at clinical facilities for repetitive MRI and clinical examinations, the system captures digital representations of patient performance across multiple domains (motor function, cognition, physiology) that can be analyzed remotely, replacing the need for repeated physical investigations.
2Reliability
If current diagnostic methods are used, then disease dissemination can be confirmed, but there is lacking a reliable means for identifying progressing forms of MS
Solution Approach 1:
The patent implements continuous feedback through repeated digital assessments that track changes in performance parameters over time. The system captures baseline measurements and compares subsequent measurements to detect deviations indicating disease progression. This feedback mechanism provides reliable identification of progressing MS forms by monitoring trends in motor function, cognitive ability, and physiological parameters, filling the information gap in traditional diagnostic methods.
Solution Approach 2:
The patent establishes baseline performance parameters through initial digital assessments before disease progression occurs. By capturing preliminary data across multiple physiological and cognitive domains, the system creates a reference framework that enables early detection of progression when deviations from baseline are detected, allowing intervention before significant disability develops.
3Reliability
If mobile device-based performance parameter determination is implemented, then reliable identification of progressing MS is achieved, but the system complexity increases
Solution Approach 1:
The patent leverages the universal nature of mobile devices that already possess multiple sensors (accelerometers, gyroscopes, cameras, microphones, touchscreens) for a single diagnostic application. Instead of requiring specialized equipment, the system repurposes existing multi-functional mobile device capabilities to capture performance parameters across motor function, cognitive ability, and physiological domains, reducing overall system complexity while maintaining diagnostic reliability.
Solution Approach 2:
The patent implements self-service functionality where the mobile device automatically captures performance parameters without requiring external diagnostic equipment or specialized operators. The device performs self-calibration, automated data collection, and preliminary analysis, reducing the complexity burden on healthcare systems by enabling patients to conduct assessments independently rather than requiring complex clinical infrastructure.
Data Source
Figure 1A~1C
Figure 2A~2B
Figure 3A~3E
AI summary
The present invention relates to the field of diagnostics. Specifically, it relates to a method of identifying progressing multiple sclerosis (MS) in a subject comprising the steps of determining at least one performance parameter determined from a dataset of activity measurements obtained from said subject using a mobile device, and comparing the determined at least one performance parameter to a reference, whereby a subject with progressing MS will be identified. Moreover, encompassed by the present invention is a method of recommending an anti-CD20 antibody therapy against MS comprising the steps of the method of the present invention and the further step of recommending the anti-CD20 antibody therapy if the subject suffers from progressing MS. The present invention also relates to a mobile device comprising a processor, at least one sensor and a database as well as software which is tangibly embedded to said device and, when running on said device, carries out the method of the invention as well as the use of such a device for identifying a subject suffering from progressing MS.